Sign In
Buy CHMA
$3.76
+0 (+0%)
At Close: May 27, 2022
Does Chiasma, Inc. (NASDAQ:CHMA) Have A High Beta?
02:17pm, Sunday, 26'th Jan 2020
Anyone researching Chiasma, Inc. (NASDAQ:CHMA) might want to consider the historical volatility of the share price...
Chiasma Announces FDA Acceptance of MYCAPSSA® New Drug Application Resubmission
12:00pm, Monday, 13'th Jan 2020
Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that the U.S. Food and Drug Admin
Chiasma Provides Corporate Update and Previews 2020 Milestones
12:00pm, Friday, 10'th Jan 2020
Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today reviewed its 2019 highlights and previewed its
Train chiefs slammed by northern leaders for 'woeful' December services
02:24pm, Wednesday, 08'th Jan 2020
Senior northern leaders grilled both Northern and Transpennine Express on a nosedive in services at the end of last year - but Northern says it couldn't have "made better decisions"
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 19.) Acceleron Pharma Inc (NASDAQ: XLRN ) Ard
Chiasma Added to NASDAQ Biotechnology Index
09:05pm, Thursday, 19'th Dec 2019
NEEDHAM, Mass., Dec. 19, 2019 -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious.
Changes to rail timetables for Huddersfield passengers revealed
01:25pm, Monday, 16'th Dec 2019
It's due to a maintenance backlog, a delay in crew training and late delivery of new trains
Hedge Funds Have Never Been This Bullish On Chiasma Inc (CHMA)
01:59am, Sunday, 15'th Dec 2019
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclos
Chiasma to Present at the Piper Jaffray 31st Annual Healthcare Conference
09:05pm, Tuesday, 26'th Nov 2019
WALTHAM, Mass., Nov. 26, 2019 -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious.
Edited Transcript of CHMA earnings conference call or presentation 5-Nov-19 10:00pm GMT
07:27am, Friday, 22'nd Nov 2019
Q3 2019 Chiasma Inc Earnings Call
Chiasma to Present at the 13th Acromegaly Consensus Conference
09:05pm, Thursday, 14'th Nov 2019
Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that William Ludlam, M.D., Ph.D., Se
Hedge Funds Have Never Been More Bullish On Chiasma Inc (CHMA)
02:39pm, Monday, 11'th Nov 2019
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good additi
Chiasma Reports Third Quarter 2019 Results
09:05pm, Tuesday, 05'th Nov 2019
CHIASMA OPTIMAL trial, conducted under SPA and designed to support FDA approval, met the primary and all secondary endpoints MYCAPSSA® NDA on track for submission by year-end.
You can now watch films and TV shows on the train - for free
09:10am, Wednesday, 01'st Aug 2018
TransPennine Express has launched streaming service Exstream on the Cleethorpes to Manchester route offering more than 150 movies and TV shows
